Call 08048274016
Send E-mail

Anti Cancer Capsules

Offering you a complete choice of products which include xtandi 40mg.
Get CALLBACK

Xtandi 40mg

Xtandi 40mg
 
Get Best Quote
Approx. Rs 5,000 / Bottle
Get Latest Price

Product Details:
Packaging Size1*10
BrandXTANDI CAPSULES
CompositionENZULUTAMIDE 40 MG
ManufacturerASO PHARMA
TreatmentEnzalutamide is used to treat prostate cancer that has spread to other parts of the body in men and
Prescription/Non prescriptionNon prescription
Deals inThird Party Manufacturing
FormTablet
Therapeutic UsesEnzalutamide is used to treat prostate cancer that has spread to other parts of the body in men and

Prostate gland is a small walnut-sized gland that produces a fluid called seminal fluid that nourishes and transports sperms in males. The most common symptom of prostate cancer is difficulty with urination, but sometimes there are no symptoms at all. Xtandi 40mg Soft Capsule decreases or stops the growth of cancer cells by decreasing the amount of testosterone (natural hormone in males) in men. This also relieves difficulty in passing urine and makes it easier for you to urinate.

Additional Information:
  • Delivery Time: 10 TO 12 DAYS
Yes! I am Interested
Explore More Products
Get Best Quote
Get Best Quote
Get Best Quote
Get Best Quote
Get Best Quote
X

Reviews & Rating

4.8/5

★★★★★★★★★★

Reviewed by 37 Users

  • 5★87%
  • 4★5%
  • 3★0%
  • 2★0%
  • 1★8%
  • User Satisfaction
  • Response90%
  • Quality     95%
  • Delivery   88%

Most Relevant Reviews

L
★★★★★★★★★★
21-November-22
Lindsay Bamford
Australia
Was able to meet all my requirements. Fast postage and quick response to emails.
Response
Quality
Delivery
H
★★★★★★★★★★
31-October-22
Hilary Yip
United Kingdom
Very helpful seller
Response
Quality
Delivery
Y
★★★★★★★★★★
26-November-22
Yassine
United Arab Emirates
Product Name : Sildenafil Tablets
Response
Quality
Delivery
View More Reviews
Find UsFiza Pharma (CEO) M/S Fiza Pharma
Plot No 235 Lodhipura Behind Empress Mill No, Nagpur - 440018, Maharashtra, India
SEND SMS
SEND E-MAIL
Share Us: